Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 8, 2026 · Leadership change · Item 5.07 · Financial statements
| ItemItem | Disclosure |
|---|---|
| Item 5.02 | Director or executive officer departure or appointment |
| Item 5.07 | Item 5.07 |
| Item 9.01 | Financial statements and exhibits |
Climb Bio, Inc. filed this to disclose a change in directors or executive officers appointments, departures, or role changes that can signal a strategic shift.
2021 EQUITY INCENTIVE PLAN ADOPTED BY THE COMPENSATION COMMITTEE OF THE BOARD OF DIRECTORS: July 26, 2021 APPROVED BY THE STOCKHOLDERS: July 29, 2021 1. (a) Successor to and Continuation of Prior Plan .
This filing reports Item 5.02 (director or executive officer departure or appointment). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Climb Bio, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
